ID30504A - Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan - Google Patents

Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan

Info

Publication number
ID30504A
ID30504A IDW00200101649A ID20011649A ID30504A ID 30504 A ID30504 A ID 30504A ID W00200101649 A IDW00200101649 A ID W00200101649A ID 20011649 A ID20011649 A ID 20011649A ID 30504 A ID30504 A ID 30504A
Authority
ID
Indonesia
Prior art keywords
spontantly
benzoil
staurosporin
dispersed
composition
Prior art date
Application number
IDW00200101649A
Other languages
English (en)
Indonesian (id)
Inventor
Graham Matthews
Barbara Haberlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10847896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30504(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID30504A publication Critical patent/ID30504A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW00200101649A 1999-02-16 2000-02-14 Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan ID30504A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903547.9A GB9903547D0 (en) 1999-02-16 1999-02-16 Organic compounds

Publications (1)

Publication Number Publication Date
ID30504A true ID30504A (id) 2001-12-13

Family

ID=10847896

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101649A ID30504A (id) 1999-02-16 2000-02-14 Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan

Country Status (34)

Country Link
US (3) US20020061873A1 (ja)
EP (1) EP1152750B1 (ja)
JP (2) JP5057610B2 (ja)
KR (2) KR20080064914A (ja)
CN (1) CN100367930C (ja)
AR (2) AR022589A1 (ja)
AT (1) ATE430554T1 (ja)
AU (1) AU765776B2 (ja)
BR (1) BRPI0008228B8 (ja)
CA (1) CA2362277C (ja)
CL (1) CL2009001682A1 (ja)
CZ (1) CZ303979B6 (ja)
DE (1) DE60042151D1 (ja)
DK (1) DK1152750T3 (ja)
EC (1) ECSP083351A (ja)
ES (1) ES2326783T3 (ja)
GB (1) GB9903547D0 (ja)
HK (1) HK1045807B (ja)
HU (1) HUP0105364A3 (ja)
ID (1) ID30504A (ja)
IL (3) IL144512A0 (ja)
MY (1) MY128362A (ja)
NO (1) NO331232B1 (ja)
NZ (1) NZ513529A (ja)
PE (1) PE20001499A1 (ja)
PL (1) PL198330B1 (ja)
PT (1) PT1152750E (ja)
RU (1) RU2266121C2 (ja)
SI (1) SI1152750T1 (ja)
SK (1) SK286967B6 (ja)
TR (1) TR200102385T2 (ja)
TW (1) TWI240636B (ja)
WO (1) WO2000048571A1 (ja)
ZA (1) ZA200106677B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
DK1372611T3 (da) * 2001-03-26 2006-09-18 Novartis Ag Farmaceutisk sammensætning omfattende staurosporin med ringe vandoplöselighed, et overfladeaktivt stof og en vandoplöselig polymer
SK14042003A3 (sk) 2001-05-16 2004-05-04 Novartis Ag Kombinácia N-{5-[4-metylpiperazinometyl)benzoylamido]-2- metylfenyl}-4-(3-pyridyl)-2-pyrimidínamínu chemoterapeutického činidla a farmaceutický prostriedok, ktorý ju obsahuje
NZ532136A (en) 2001-10-30 2006-08-31 Novartis Ag Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
CN101897662B (zh) * 2002-07-23 2013-05-22 诺瓦提斯公司 包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
GB0419159D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
PT2054040E (pt) * 2006-08-16 2011-06-30 Novartis Ag Método para produzir dispersões sólidas de compostos terapêuticos altamente cristalinos
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090155352A1 (en) * 2007-11-20 2009-06-18 Cephalon, Inc. Microemulsion containing indolocarbazole compound and dosage forms containing the same
EP2229936B1 (en) * 2009-03-09 2015-05-06 PharmaSol GmbH Nanonized testosterone formulations for improved bioavailability
WO2011000811A2 (en) * 2009-06-30 2011-01-06 Novartis Ag Organic compounds
JP5873439B2 (ja) * 2009-12-22 2016-03-01 レオ ファーマ アクティーゼルスカブ ビタミンｄ類似体および溶媒と界面活性剤の混合物を含む皮膚組成物
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
WO2013042069A1 (en) 2011-09-22 2013-03-28 Ariel-University Research And Development Company, Ltd. Emulsions and methods of making emulsions
KR20190032265A (ko) * 2015-12-09 2019-03-27 포스파제닉스 리미티드 약제학적 제형
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
WO2021097256A1 (en) 2019-11-14 2021-05-20 Cohbar, Inc. Cxcr4 antagonist peptides

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4735939A (en) 1987-02-27 1988-04-05 The Dow Chemical Company Insecticidal activity of staurosporine
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
DE3824034C1 (ja) * 1988-07-15 1989-09-14 Gustav 7290 Freudenstadt De Memminger
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
WO1992018147A1 (en) 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5639474A (en) 1993-07-01 1997-06-17 Hanmi Pharm. Ind., Ltd. Cyclosporin soft capsule composition
JPH09510182A (ja) 1993-11-17 1997-10-14 エルディーエス・テクノロジーズ・インコーポレーテッド カプセル封入されたドラッグデリバリー用透明液
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
WO1995022331A1 (en) 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
AU2565895A (en) * 1994-06-01 1995-12-21 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
GB2308545B (en) 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
PE52896A1 (es) 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
EP0711557A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage
EP0733372A3 (de) * 1995-03-21 1998-05-20 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
AU4491697A (en) 1996-09-27 1998-04-17 Trega Biosciences, Inc. Compositions of therapeutic agents suitable for oral administration
DE19641672A1 (de) 1996-10-10 1998-04-16 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen auf der Basis von ethylenoxidfreien und propylenoxidfreien Emulgatoren zur Herstellung von Mikroemulsionsgelen
US5827522A (en) 1996-10-30 1998-10-27 Troy Corporation Microemulsion and method
NZ314060A (en) 1997-01-13 1997-08-22 Bernard Charles Sherman Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s)
DE29824679U1 (de) * 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
KR100509130B1 (ko) 1997-07-29 2005-08-18 파마시아 앤드 업존 캄파니 엘엘씨 친지성 화합물의 자가유화 제제
BR9811058A (pt) 1997-07-29 2000-09-05 Upjohn Co Formulação auto-emulsificante para compostos lipofìlicos
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
AR013276A1 (es) 1998-07-31 2000-12-13 Panacea Biotec Ltd Composicion de ciclosporina transparente
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0105364A3 (en) 2003-02-28
BR0008228A (pt) 2001-10-30
US8575147B2 (en) 2013-11-05
AU3154200A (en) 2000-09-04
HUP0105364A2 (hu) 2002-05-29
IL192666A0 (en) 2009-02-11
DK1152750T3 (da) 2009-08-24
CL2009001682A1 (es) 2010-07-23
AU765776B2 (en) 2003-10-02
PL350556A1 (en) 2002-12-16
JP5057610B2 (ja) 2012-10-24
US20020061873A1 (en) 2002-05-23
WO2000048571A1 (en) 2000-08-24
ES2326783T3 (es) 2009-10-20
CZ303979B6 (cs) 2013-07-31
GB9903547D0 (en) 1999-04-07
AR022589A1 (es) 2002-09-04
ATE430554T1 (de) 2009-05-15
CZ20012931A3 (cs) 2001-11-14
SK11722001A3 (sk) 2001-12-03
NO20013964L (no) 2001-10-15
CA2362277A1 (en) 2000-08-24
NO331232B1 (no) 2011-11-07
HK1045807A1 (en) 2002-12-13
US20080070897A1 (en) 2008-03-20
SK286967B6 (sk) 2009-08-06
CN100367930C (zh) 2008-02-13
US8722664B2 (en) 2014-05-13
TR200102385T2 (tr) 2002-09-23
US20140056974A1 (en) 2014-02-27
PL198330B1 (pl) 2008-06-30
PT1152750E (pt) 2009-08-07
EP1152750A1 (en) 2001-11-14
NO20013964D0 (no) 2001-08-15
ECSP083351A (es) 2008-08-29
MY128362A (en) 2007-01-31
JP2012111763A (ja) 2012-06-14
BRPI0008228B8 (pt) 2021-05-25
HK1045807B (zh) 2008-12-05
ZA200106677B (en) 2003-01-14
RU2266121C2 (ru) 2005-12-20
JP2002537242A (ja) 2002-11-05
KR100880859B1 (ko) 2009-01-30
NZ513529A (en) 2003-10-31
IL144512A (en) 2011-03-31
CN1339963A (zh) 2002-03-13
DE60042151D1 (de) 2009-06-18
SI1152750T1 (sl) 2009-10-31
IL144512A0 (en) 2002-05-23
BRPI0008228B1 (pt) 2016-08-23
PE20001499A1 (es) 2001-01-12
KR20010093281A (ko) 2001-10-27
KR20080064914A (ko) 2008-07-09
CA2362277C (en) 2010-03-30
TWI240636B (en) 2005-10-01
EP1152750B1 (en) 2009-05-06
AR082579A2 (es) 2012-12-19

Similar Documents

Publication Publication Date Title
ID30504A (id) Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan
NO20021116D0 (no) Ny sammensetning
IS6120A (is) Lyfjablanda
DE60027505D1 (de) Schleifmittelzusammensetzung
DE60002795D1 (de) Bindermittelzusammensetzung
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
DE60014907D1 (de) Schleifmittelzusammensetzung
ID29430A (id) Komposisi herbisida
EE200100420A (et) Kütusekoostis
DE60014179D1 (de) Tintenzusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
NO20021115L (no) Ny sammensetning
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
DE69943245D1 (de) Gaserzeugende zusammensetzung
FI19992609A (fi) Uusi koostumus
FR2791258B1 (fr) Composition amincissante
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ID26295A (id) Komposisi keras-ultraviolet
ID26485A (id) Komposisi paroksetina
ID27329A (id) Komposisi penghambat